Results 191 to 200 of about 51,657 (292)

From adipokine to integrator: longitudinal galectin-1 changes mirror glycemic, hepatic, renal, and lipid remodeling after bariatric surgery. [PDF]

Nutr Diabetes
Chen TH, Lin YJ, Yang WS, Lee PC, Chen CN, Lin MT, Yang PJ.   +6 more
europepmc   +1 more source

Beyond Traditional Screening: The Future of Heart Failure Detection With Biomarkers and AI

iNew Medicine, Volume 2, Issue 3, September 2026.
Advancing HF Screening: Integrating Technology and Risk Factors Across Eras. This diagram provides a comprehensive review of the historical developments and projected trends of heart failure (HF) screening methodologies, with the prevalent risk factors for HF depicted at the base.
Xiaofeng Fang, Yinbo Xu, Yiting Zhao, Liuyi Li, Zhengyi Cheng, Zhongqi Zhang, Yuhang Luo, Qiaoling Liu, Chen Gong, Shichun Shen   +9 more
wiley   +1 more source

Single-cell RNA sequencing reveals dysregulation of innate immune signaling in early-life respiratory syncytial virus infection with subsequent low-level cadmium exposure. [PDF]

Toxicol Rep
Jarrell ZR, Lee HY, Jeon J, Lim G, Lee CM, Kang SM, Chen Y, Jones DP, Go YM.   +8 more
europepmc   +1 more source

A pilot study of Galectin-3 targeting in chronic kidney fibrosis and kidney function decline. [PDF]

BMC Nephrol
Qin A, Zhou W, Zhang Z, Zhou Q, Wang J, Wang Z, Zhou Z, Sun Q, Su L, Peng Z.   +9 more
europepmc   +1 more source

Cell Death in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets

MedComm, Volume 7, Issue 9, September 2026.
Regulated cell death pathways, including apoptosis, necroptosis, pyroptosis, ferroptosis, and autophagy‐dependent cell death, interact with mitochondrial dysfunction, proteostasis failure, lysosomal stress, glial remodeling, and neuroinflammation across major neurodegenerative diseases.
Tianjiao Li, Qian Zhang, Yichen Wu, Ruixue Huang   +3 more
wiley   +1 more source

Mechanisms and therapeutic implications of galectins regulating Epstein-Barr virus infection. [PDF]

Virus Res
Huang JY, Baua AD, Yang ZS, Tsui CI, Chen PC, Wang WH, Assavalapsakul W, Thitithanyanont A, Chen YH, Wang SF.   +9 more
europepmc   +1 more source

Protein Posttranslational Modifications in Immunity: Molecular Mechanisms and Therapeutic Targets

MedComm, Volume 7, Issue 9, September 2026.
Protein posttranslational modifications, including phosphorylation, ubiquitination, SUMOylation, acetylation, methylation, glycosylation, and other new types, dynamically regulate antigen presentation and recognition, immune signal transduction, antibody production and class switching, immune contraction, immune memory establishment, as well as immune ...
Yuxing Yao, Jinxiu Qian, Qiqiong Liu, Wanting Ye, Ying Xing, Xiuyun Bai, Rongjun Deng, Jue Yang, Cheng Lu, Cheng Xiao, Yuanyan Liu   +10 more
wiley   +1 more source

Discovery of dynamic tumor microenvironment architecture with targeted agents in the multiplex implantable microdevice assay. [PDF]

Signal Transduct Target Ther
Jakubik J, Tatarova Z.
europepmc   +1 more source

Patent Foramen Ovale: Epidemiology, Risk Factors, Pathophysiology, Clinical Features, Diagnosis, and Management

MedComm, Volume 7, Issue 9, September 2026.
The clinical manifestations of PFO. Although the majority of PFOs are benign and asymptomatic, they can present with a variety of clinical manifestations, or coexisting with other diseases and aggravating their symptoms, including cerebral diseases (such as CS, epilepsy, TIA, or migraine), systemic embolism (such as embolism in renal artery, coronary ...
Linlin Meng, Xiaotong Zhang, Guangrui Sun, Honggang Dai, Xiao Meng, Cheng Zhang, Yun Zhang   +6 more
wiley   +1 more source

Correction to "Therapeutic Galectin-3 Apheresis Improves Sepsis Outcomes through Coordinated Neutrophil Modulation and Endothelial Barrier Preservation: A Translational Study". [PDF]

MedComm (2020)
europepmc   +1 more source